Aim of this study was to assess the efficacy, adherence and patient-related outcomes of a simplification strategy in patients switching from a stable regimen containing tenofovir and lamivudine to fixed dose combination with tenofovir + emtricitabine.
Simplification to TDF+FTC fixed dose combination shows improved immunological response, adherence and patient-related outcomes while maintaining virological efficacy (the MULTIFACTORS Back Study) / Guaraldi, Giovanni; Marcotullio, S.; von Schloesser, F.; Ciaffi, S.; Mazeu, I.; Pellicanò, G.; Scavello, G.; Orofino, G.; Sighinolfi, L.; Murri, R.. - STAMPA. - 104:(2008), pp. 40-40. (Intervento presentato al convegno 3rd Conference on HIV Treatment Adherence tenutosi a Jersey city, New Jersey nel March 17- 18-2008).
Simplification to TDF+FTC fixed dose combination shows improved immunological response, adherence and patient-related outcomes while maintaining virological efficacy (the MULTIFACTORS Back Study)
GUARALDI, Giovanni;
2008
Abstract
Aim of this study was to assess the efficacy, adherence and patient-related outcomes of a simplification strategy in patients switching from a stable regimen containing tenofovir and lamivudine to fixed dose combination with tenofovir + emtricitabine.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
